E
OCDX

Ergoteles’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Ergoteles’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-352,777
Closed -$6.58M – 2145
2022
Q1 		$6.58M Buy
+352,777
New +$6.35M 0.25% 104

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Ergoteles's OCDX Position: Q2 2022 in Review

Ergoteles sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 352,777 shares — an estimated $6.58M sold.

Ergoteles first reported a position in OCDX in Q1 2022 and held it in 1 quarter. The position peaked at $6.58M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Ergoteles reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Ergoteles sold 352,777 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $6.58M.
  • Ergoteles first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2022 and held it in 1 quarter.
  • Ergoteles's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $6.58M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Ergoteles's 13F filing for Q2 2022, filed 12 Aug 2022.